Anti-pd-1 antibody and medical use thereof

MYPI2025002140A0Undetermined Publication Date: 2021-02-02CTTQ AKESO (SHANGHAI) BIOMED TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002140
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-11-19
Filing Date
2020-07-31
Publication Date
2021-02-02
Patent Text Reader

Abstract

Disclosed is a monoclonal anfibody. The monoclonal anfibody has a heavy chain variable region comprising a CDR with an amino acid sequence of SEQ ID NOs: 19 - 21 and / or a light chain variable region comprising a CDR with an amino acid sequence of SEQ ID NOs: 22 - 24. Using the EU numbering system, the anfibody has a heavy chain constant region mutated at any two or three of posifions 234, 235, and 237. The affinity constant of the mutated anfibody to FCγRIIIa and / or C1q is lower than that before the mutafion. Fig. 34
Need to check novelty before this filing date? Find Prior Art